Titan Medical (NASDAQ:TMDI) Receives “Buy” Rating from Northland Securities

Northland Securities reiterated their buy rating on shares of Titan Medical (NASDAQ:TMDI) in a report released on Thursday, AnalystRatings.com reports.

“We waited to have a call with management, and our summary underneath is a reflection of the information gleaned from our conversation.”,” the firm’s analyst wrote.

Several other research firms also recently commented on TMDI. ValuEngine upgraded Zogenix from a buy rating to a strong-buy rating in a research report on Thursday, June 27th. Piper Jaffray Companies dropped their target price on Pure Storage from $25.00 to $20.00 and set an overweight rating for the company in a research report on Wednesday, May 22nd. Finally, Zacks Investment Research downgraded Hollysys Automation Technologies from a hold rating to a sell rating in a research report on Thursday, April 11th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has an average rating of Buy and a consensus target price of $5.56.

Titan Medical stock opened at $2.15 on Thursday. The company has a market capitalization of $46.60 million and a P/E ratio of -1.58. Titan Medical has a 12 month low of $1.05 and a 12 month high of $4.65. The company has a 50-day moving average price of $2.31.

An institutional investor recently bought a new position in Titan Medical stock. Pathlight Investors LLC acquired a new position in shares of Titan Medical Inc. (NASDAQ:TMDI) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 16,439 shares of the company’s stock, valued at approximately $39,000. Pathlight Investors LLC owned 0.12% of Titan Medical at the end of the most recent reporting period. 13.07% of the stock is owned by institutional investors.

Titan Medical Company Profile

Titan Medical Inc, a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures.

Recommended Story: Institutional Investors

Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.